Cabot (NYSE:CBT) Issues Quarterly Earnings Results

Cabot (NYSE:CBT) posted its earnings results on Monday. The specialty chemicals company reported $1.80 EPS for the quarter, missing analysts’ consensus estimates of $1.81 by ($0.01), Briefing.com reports. The business had revenue of $1 billion during the quarter, compared to analysts’ expectations of $1.01 billion. Cabot had a net margin of 12.05% and a return on equity of 26.99%. Cabot’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.65 EPS. Cabot updated its FY 2025 guidance to 7.400-7.800 EPS and its FY25 guidance to $7.40-7.80 EPS.

Cabot Stock Performance

Shares of CBT stock opened at $108.88 on Wednesday. Cabot has a 52 week low of $66.02 and a 52 week high of $117.14. The firm has a 50 day moving average of $108.41 and a two-hundred day moving average of $101.13. The company has a quick ratio of 1.45, a current ratio of 2.22 and a debt-to-equity ratio of 0.72. The stock has a market capitalization of $5.97 billion, a PE ratio of 12.95, a P/E/G ratio of 0.91 and a beta of 1.20.

Wall Street Analyst Weigh In

A number of research firms have commented on CBT. JPMorgan Chase & Co. upped their target price on shares of Cabot from $95.00 to $105.00 and gave the company a “neutral” rating in a research report on Wednesday, August 7th. Mizuho upped their price objective on shares of Cabot from $103.00 to $122.00 and gave the stock an “outperform” rating in a report on Tuesday. Finally, UBS Group cut their target price on Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 6th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $105.00.

Insider Activity

In related news, EVP Jeff Ji Zhu sold 1,201 shares of the business’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $106.19, for a total transaction of $127,534.19. Following the completion of the transaction, the executive vice president now directly owns 96,000 shares of the company’s stock, valued at $10,194,240. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, EVP Jeff Ji Zhu sold 1,201 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $106.19, for a total transaction of $127,534.19. Following the completion of the transaction, the executive vice president now directly owns 96,000 shares of the company’s stock, valued at approximately $10,194,240. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Erica Mclaughlin sold 16,390 shares of the firm’s stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $104.24, for a total transaction of $1,708,493.60. Following the completion of the sale, the chief financial officer now directly owns 59,814 shares in the company, valued at approximately $6,235,011.36. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 48,665 shares of company stock worth $4,986,299. Corporate insiders own 3.07% of the company’s stock.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.